Skip to ContentSkip to Navigation
About us Practical matters How to find us E.A.M. Festen

Publications

Exploring diet categorizations and their influence on flare prediction in inflammatory bowel disease, using the Sparse Grouped Least Absolute Shrinkage and Selection Operator method

Genome-wide meta-analysis associates donor-recipient non-HLA genetic mismatch with acute cellular rejection post-liver transplantation

Gut microbiome dysbiosis is not associated with portal vein thrombosis in patients with end-stage liver disease: a cross-sectional study

Insights in Cellular and Molecular Signatures of the Small Intestinal Graft Posttransplantation: Successful, Recovered, and Rejected - A Case Series

Biologicals in the prevention and treatment of intestinal graft rejection: The state of the art Biologicals in Intestinal Transplantation

Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study

Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease

Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content

Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease

Inflammatory Bowel Disease in patients with Primary Sclerosing Cholangitis: a distinct form of colitis

Press/media

Effectiviteit van medicijnen voorspellen bij chronische darmziekte colitis ulcerosa